Project Details
Description
A Phase II, Randomized, Multicenter Study of PEGPH20 (PEGylated Recombinant Human Hyaluronidase) Combined with nab-Paclitaxel Plus Gemcitabine Compared With nab-Paclitaxel Plus Gemcitabine in Subject with Stage IV previously untreated Pancreatic Cancer
| Status | Finished |
|---|---|
| Effective start/end date | 5/10/13 → 11/30/19 |
Funding
- HALOZYME, INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.